SUMMIT, N.J., Sept. 21, 2020 /PRNewswire/ -- Seqirus, a global leader in influenza prevention, today announced the publication of new real-world evidence (RWE) that demonstrated an MF59® adjuvanted, ...
Quadrivalent recombinant influenza vaccines contain three times the amount of hemagglutinin protein as standard-dose egg-based vaccines, and the recombinant formulation is not susceptible to antigenic ...
This is a preview. Log in through your library . Abstract Purpose The aim of this study is to investigate the role of health-related quality-of-life (QoL) data in relative effectiveness assessments ...
In a recent study published on the medRxiv* preprint server, researchers have revealed that a booster dose of a messenger ribonucleic acid (mRNA)-based coronavirus disease 2019 (COVID-19) vaccine is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results